These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 27494080)

  • 1. Raynaud's syndrome in children: systematic review and development of recommendations for assessment and monitoring.
    Pain CE; Constantin T; Toplak N; Moll M; Iking-Konert C; Piotto DP; Aktay Ayaz N; Nemcova D; Hoeger PH; Cutolo M; Smith V; Foeldvari I;
    Clin Exp Rheumatol; 2016; 34 Suppl 100(5):200-206. PubMed ID: 27494080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Minimal work-up for Raynaud syndrome: a consensus report. Microcirculation working group of the Société française de médecine vasculaire].
    Pistorius MA; Carpentier PH;
    Ann Dermatol Venereol; 2013; 140(8-9):549-54. PubMed ID: 24034643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective nailfold capillaroscopy evaluation of Raynaud's phenomenon in children and adolescents.
    Piotto DG; Hilário MO; Carvalho NS; Len CA; Andrade LE; Terreri MT
    Acta Reumatol Port; 2013; 38(2):114-21. PubMed ID: 24141348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Minimal work-up for Raynaud syndrome: a consensus report. Microcirculation Working Group of the French Vascular Medicine Society].
    Pistorius MA; Carpentier PH;
    J Mal Vasc; 2012 Jul; 37(4):207-12. PubMed ID: 22749761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nailfold capillaroscopic findings in primary Sjögren's syndrome with and without Raynaud's phenomenon and/or positive anti-SSA/Ro and anti-SSB/La antibodies.
    Corominas H; Ortiz-Santamaría V; Castellví I; Moreno M; Morlà R; Clavaguera T; Erra A; Martínez-Pardo S; Ordóñez S; Santo P; Reyner P; González MJ; Codina O; Gelman MS; Juanola-Roura X; Olivé A; Torrente-Segarra V;
    Rheumatol Int; 2016 Mar; 36(3):365-9. PubMed ID: 26597492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Associations of nailfold capillary abnormalities and immunological markers in early Raynaud's phenomenon.
    Schlager O; Kiener HP; Stein L; Hofkirchner J; Zehetmayer S; Ristl R; Perkmann T; Smolen JS; Koppensteiner R; Gschwandtner ME
    Scand J Rheumatol; 2014; 43(3):226-33. PubMed ID: 24517537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prognostic factors in Raynaud's phenomenon: usefulness of antinuclear antibodies and of periungual capillaroscopy].
    Passiu G; Sebastiani GD; Galeazzi M; Tuveri MA; Nicosia PM; Boirivant R
    Medicina (Firenze); 1990; 10(4):405-7. PubMed ID: 2099984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary care assessment of capillaroscopy abnormalities in patients with Raynaud's phenomenon.
    Overbury R; Murtaugh MA; Fischer A; Frech TM
    Clin Rheumatol; 2015 Dec; 34(12):2135-40. PubMed ID: 26400642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Position article and guidelines 2018 recommendations of the Brazilian Society of Rheumatology for the indication, interpretation and performance of nailfold capillaroscopy.
    Kayser C; Bredemeier M; Caleiro MT; Capobianco K; Fernandes TM; de Araújo Fontenele SM; Freire E; Lonzetti L; Miossi R; Sekiyama J; de Souza Müller C
    Adv Rheumatol; 2019 Jan; 59(1):5. PubMed ID: 30670098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progression of patients with Raynaud's phenomenon to systemic sclerosis: a five-year analysis of the European Scleroderma Trial and Research group multicentre, longitudinal registry study for Very Early Diagnosis of Systemic Sclerosis (VEDOSS).
    Bellando-Randone S; Del Galdo F; Lepri G; Minier T; Huscher D; Furst DE; Allanore Y; Distler O; Czirják L; Bruni C; Guiducci S; Avouac J; Cutolo M; Smith V; Matucci-Cerinic M;
    Lancet Rheumatol; 2021 Dec; 3(12):e834-e843. PubMed ID: 38287630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of hallmark autoantibody reactivity on early diagnosis in scleroderma.
    Moinzadeh P; Nihtyanova SI; Howell K; Ong VH; Denton CP
    Clin Rev Allergy Immunol; 2012 Dec; 43(3):249-55. PubMed ID: 22711501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Etiological profile of secondary Raynaud's phenomenon in an internal medicine department. About 121 patients].
    Ben Salem T; Tougorti M; Bziouech S; Lamloum M; Khanfir M; Ben Ghorbel I; Houman MH
    J Med Vasc; 2018 Feb; 43(1):29-35. PubMed ID: 29425538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Raynaud's phenomenon - first sign of malignancy: case report].
    Sutić A; Gračanin G; Morović-Vergles J
    Acta Med Croatica; 2014 Jun; 68(3):295-8. PubMed ID: 26016221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Raynaud's features in childhood. Clinical, immunological and capillaroscopic study.
    Navon P; Yarom A; Davis E
    J Mal Vasc; 1992; 17(4):273-6. PubMed ID: 1494054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of transition from primary Raynaud's phenomenon to secondary Raynaud's phenomenon by nailfold videocapillaroscopy: comment on the article by Hirschl et al.
    Cutolo M; Pizzorni C; Sulli A
    Arthritis Rheum; 2007 Jun; 56(6):2102-3; author reply 2103-4. PubMed ID: 17530659
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical applicability of quantitative nailfold capillaroscopy in differential diagnosis of connective tissue diseases with Raynaud's phenomenon.
    Wu PC; Huang MN; Kuo YM; Hsieh SC; Yu CL
    J Formos Med Assoc; 2013 Aug; 112(8):482-8. PubMed ID: 24016612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Raynaud's syndrome in children. Study of 23 cases].
    Koné-Paut I; Olivar E; Elbhar C; Garnier JM; Berbis P
    Arch Pediatr; 2002 Apr; 9(4):365-70. PubMed ID: 11998421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Systemic sclerosis - diagnosis and classification].
    Genth E; Krieg T
    Z Rheumatol; 2006 Jul; 65(4):268-74. PubMed ID: 16804700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic inflammation predicts long-term mortality in patients with Raynaud's phenomenon.
    Mueller M; Gschwandtner ME; Gamper J; Giurgea GA; Kiener HP; Perkmann T; Koppensteiner R; Schlager O
    J Intern Med; 2018 Mar; 283(3):293-302. PubMed ID: 29068146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of endothelin-1 and selected cytokines in the pathogenesis of Raynaud's phenomenon associated with systemic connective tissue diseases.
    Rychlik-Golema W; Mastej K; Adamiec R
    Int Angiol; 2006 Jun; 25(2):221-7. PubMed ID: 16763543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.